CNR1 and metabolic syndrome: Notably, hyperactivation of CB1 has been implicated in promoting metabolic processes leading to weight gain, lipogenesis, insulin resistance, and dyslipidemia (Cota et al., 2003; Di Marzo et al., 2001; Liu et al., 2012).